Cargando…
The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
The development of refractory tumor cells limits therapeutic efficacy in cancer by activating mechanisms that promote cellular proliferation, migration, invasion, metastasis, and survival. Benzimidazole anthelmintics have broad-spectrum action to remove parasites both in human and veterinary medicin...
Autores principales: | Son, Deok-Soo, Lee, Eun-Sook, Adunyah, Samuel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458798/ https://www.ncbi.nlm.nih.gov/pubmed/32895616 http://dx.doi.org/10.4110/in.2020.20.e29 |
Ejemplares similares
-
Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics
por: Song, Bomi, et al.
Publicado: (2022) -
Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy
por: Florio, Rosalba, et al.
Publicado: (2021) -
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer
por: Florio, Rosalba, et al.
Publicado: (2019) -
Anthelmintics for drug repurposing: Opportunities and challenges
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2021) -
Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018)